KIMS Hospitals Launches Institute of Advanced Neurosciences

IMT News Desk
IMT News Desk
· 2 min read
KIMS Hospitals Bengaluru launches the Institute of Advanced Neurosciences, a new Centre of Excellence featuring state-of-the-art neurosurgery

KIMS Hospitals (Krishna Institute of Medical Sciences) Bengaluru inaugurated the “Institute of Advanced Neurosciences”– a dedicated Centre of Excellence offering comprehensive care across epilepsy, cerebrovascular disorders, neurointerventional, skull base, and spine surgery.

The newly launched centre brings together advanced infrastructure and multidisciplinary expertise, featuring facilities such as neuro rehabilitation, neuro cath lab, EEG and ENMG labs, video EEG labs, a virtual reality neurosurgery lab, and state-of-the-art neurosurgery operating theatres.

With the launch of the Institute of Advanced Neurosciences, KIMS Hospitals reaffirms its dedication to the delivery of world-class healthcare while tackling the growing prevalence of neurological diseases through innovation, expertise, and compassionate care.

The institute was inaugurated in the presence of Prof. Jawahar Doreswamy, Chancellor, PES University; Dr. B. Bhaskar Rao, Chairman and Managing Director, KIMS Group of Hospitals; Dr. Nitish Shetty, Managing Director, KIMS Hospitals, Bengaluru; Dr. R. Chinnadurai, Regional Medical Director and Chief of Adult Medical Intensive Care & Emergency Services, KIMS Hospitals, Bengaluru; Dr. B. Ravi Mohan Rao, Director & Senior Consultant, Neurosurgery, KIMS Hospitals, Electronic City; Dr. Sujit Kumar, Director & Senior Consultant, Neurology, KIMS Hospitals, Electronic City; Dr. Dinesh Nayak S, Senior Consultant & Associate Director, Neurology & Epilepsy, KIMS Hospitals, Electronic City, and leading experts in the field of neurosciences.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk